Gereon Gabelein
Overview
Explore the profile of Gereon Gabelein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
18
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hollander S, von Heesen M, Gabelein G, Mercier J, Laschke M, Menger M, et al.
Sci Rep
. 2025 Jan;
15(1):2753.
PMID: 39843785
Cilostazol has previously been shown to reduce liver steatosis and enhance hepatic perfusion. We investigated the effects of cilostazol after major hepatectomy in a steatotic rat model. Six weeks prior...
2.
Spiliotis A, Hollander S, Wagenpfeil G, Eisele R, Nika S, Mallis Kyriakides O, et al.
Sci Rep
. 2024 Jul;
14(1):17361.
PMID: 39075095
Electrochemotherapy (ECT) combines the reversible electroporation (rEP) with intravenous (i.v.) or intratumoral (i.t.) administration of chemotherapeutic drugs. We conducted this study to compare the efficacy of i.v., i.t., and i.v. ...
3.
Hollander S, Gabelein G, Al-Ali A, Spiliotis A, Scherber P, Glanemann M
Obes Surg
. 2023 Aug;
33(10):3332-3333.
PMID: 37646905
No abstract available.
4.
Spiliotis A, Hollander S, Rudzitis-Auth J, Wagenpfeil G, Eisele R, Nika S, et al.
Cancers (Basel)
. 2023 Mar;
15(5).
PMID: 36900388
Background: The available ablative procedures for the treatment of hepatic cancer have contraindications due to the heat-sink effect and the risk of thermal injuries. Electrochemotherapy (ECT) as a nonthermal approach...
5.
Lahes S, Fischer C, Spiliotis A, Schulz A, Gabelein G, Igna D, et al.
Int J Colorectal Dis
. 2022 Nov;
37(12):2535-2542.
PMID: 36441196
Background: Immunosuppressants represent an effective pharmacological treatment for the remission and management of Crohn's disease (CD); however, it has not been well-defined if these medications are associated with an increased...
6.
Hollander S, Gabelein G, Spiliotis A, Scherber P, Glanemann M
Obes Surg
. 2022 Jul;
32(9):3208-3209.
PMID: 35810268
No abstract available.
7.
Spiliotis A, Gabelein G, Malinowski M, Hollander S, Scherber P, Glanemann M
Minerva Surg
. 2022 Mar;
77(1):1-13.
PMID: 35315265
Background: Esophagectomy is associated with increased rate of postoperative complications, making it one of the procedures with the highest impact on patients' quality of life. Hybrid Ivor Lewis esophagectomy (HMIE)...
8.
Scherber P, Gabelein G, Spiliotis A, Igna D, Hollander S, Jacob P, et al.
Minerva Surg
. 2022 Mar;
77(6):550-557.
PMID: 35230040
Background: Utilization of preoperative biliary drainage prior to pancreatoduodenectomy for patients with pancreatic ductal adenocarcinoma and obstructive jaundice remains controversial. Methods: All patients that underwent pancreatoduodenectomy for pancreatic ductal adenocarcinoma...
9.
Eisele R, Scherber P, Schluter M, Drews T, Glanemann M, Gabelein G
Technol Health Care
. 2021 Aug;
30(3):683-689.
PMID: 34397442
Background: Thermoablation is an attractive treatment of thyroid nodules for its minimal-invasiveness. It remains unclear whether results and morbidity meet the patients' expectations. Objective: The aim of the presented study...
10.
Hollander S, von Heesen M, von Heesen A, Spiliotis A, Gabelein G, Scherber P, et al.
J Laparoendosc Adv Surg Tech A
. 2021 Jul;
32(5):515-521.
PMID: 34283667
Evidence is lacking concerning a clear benefit of single-port laparoscopic cholecystectomy (SILC) and transvaginal cholecystectomy (TVC) over the classical laparoscopic cholecystectomy (CLC). In this study, we investigated the preferences of...